NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Multiply Labs

Multiply Labs

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://multiplylabs.com/

Last Round

Early Funding

Mar 18, 2026

Est. Valuation

$60M

Total Funding Raised

$43.42M

Company Overview

Multiply Labs is a biotechnology company that creates advanced robotics technology for the production of personalized pharmaceutical capsules and cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Industrial Robotics, Biotech Equipment, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS

AI Layer

Infrastructure

Keywords

cell and gene therapybiomanufacturingrobotic manufacturingphysical AIlab automationgood manufacturing practiceGMPCAR-T manufacturingdigital twinbiotech automationrobotics platformprocess automationbiotech roboticssmart manufacturingpharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Multiply Labs Comps

Public and private peers based on sector, stage, and business model.

Multiply Labs comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Multiply Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 18, 2026
Series A ExtensionApr 21, 2023
Series AApr 14, 2021
SeedMay 2, 2017
AcceleratorAug 20, 2016

Key People

Founding team and executive leadership

Fred Parietti

Co-Founder And CEO

Founding Team

Multiply Labs Investors

Notable investors and investment history

Multiply Labs investors
InvestorRounds
Pathfinder Venture CapitalSeries A
Lux CapitalSeries A
Garage CapitalSeries A
Fenox Venture CapitalSeed
ChinaRock Capital ManagementSeed
CRCM VenturesSeed
Sorenson CapitalEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Study in Cytotherapy highlights statistical equivalence of automated cell expansion.

  • Sep 30, 2025

    Collaboration with Thermo Fisher Scientific has been expanded.

Multiply Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Multiply Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Multiply Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range76
Year Founded2016
Last FundingMar 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.